Antibacterial medicine sales in Australia are forecasted to grow from 422.0 million AUD in 2024 to 452.0 million AUD in 2028, indicating a gradual upward trend. The market stood at 414.0 million AUD in 2023. The year-on-year variation shows a consistent growth of around 1.9% to 1.8% over the forecasted years. The Compound Annual Growth Rate (CAGR) over the 5-year period from 2023 to 2028 is approximately 1.8%, reflecting stable, albeit modest, market expansion.
Future trends to watch for:
- Potential impacts of increasing antibiotic resistance
- Market developments due to evolving regulations and healthcare policies
- Advances in pharmaceutical technology leading to the introduction of new antibacterial agents
- Influence of global health trends and potential future pandemics
- Economic factors influencing healthcare budgets and pharmaceutical expenditures
